Muenter
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 2
-
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 2
-
- Attention Deficit Hyperactivity Disorder 1
-
- Amino Acid Enzymes and Metabolism 1
-
- Diet and metabolism studies 1
-
- Metabolism and Genetic Disorders 1
- Journals
- PubMed (8 papers)
In The Last Decade
Muenter
8 papers receiving 378 citations
Peers
Comparison fields: 5 of 49
- Neurology 360
- Cellular and Molecular Neuroscience 150
- Neurology 23
- Psychiatry and Mental health 35
- Cognitive Neuroscience 36
Countries citing papers authored by Muenter
This map shows the geographic impact of Muenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muenter more than expected).
Fields of papers citing papers by Muenter
This network shows the impact of papers produced by Muenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muenter. The network helps show where Muenter may publish in the future.
Co-authorship network
The 2 scholars most cited alongside Muenter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease. | 1977 | 119 |
| 2 | Effect of L-DOPA on endogenous histamine metabolism. | 1975 | 8 |
| 3 | 3-O-Methyldopa in Parkinson's disease. | 1974 | 16 |
| 4 | 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease. | 1973 | 23 |
| 5 | Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease. | 1972 | 17 |
| 6 | L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. | 1971 | 207 |
| 7 | Dihydroxyphenylalanine (DOPA) in plasma during dopa treatment of patients with Parkinson's disease. | 1970 | 13 |
| 8 | Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease. | 1970 | 9 |
About Muenter
Muenter is a scholar working on Neurology, Clinical Biochemistry, Biochemistry, Psychiatry and Mental health and Physiology, having authored 8 papers that have together received 412 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (2 papers), Amino Acid Enzymes and Metabolism (1 paper), Diet and metabolism studies (1 paper), Metabolism and Genetic Disorders (1 paper) and Attention Deficit Hyperactivity Disorder (1 paper). The work is most often cited by research in Neurology (360 citations), Cellular and Molecular Neuroscience (150 citations), Neurology (23 citations), Psychiatry and Mental health (35 citations) and Cognitive Neuroscience (36 citations). Frequent co-authors include Tyce Gm and Owen Ca. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.